Literature DB >> 31777246

Prediction of Adverse Drug Reactions by Combining Biomedical Tripartite Network and Graph Representation Model.

Rui Xue1, Jie Liao1, Xin Shao1, Ke Han1, Jingbo Long1, Li Shao2, Ni Ai1, Xiaohui Fan1.   

Abstract

As one of the primary contributors to high clinical attrition rates of drugs, toxicity evaluation is of critical significance to new drug discovery. Unsurprisingly, a vast number of computational methods have been developed at various stages of development pipeline to evaluate potential adverse drug reactions (ADRs). Despite previous success of these methods on individual ADR or certain drug family, there are great challenges to toxicity evaluation. In this study, a novel strategy was developed to predict the drug-ADR associations by combining deep learning and the biomedical tripartite network. This heterogeneous network contains biomedical linked data of three entities, for example, drugs, targets, and ADRs. For the first time, GraRep, a deep learning method for distributed representations, is introduced to learn graph representations and identify hidden features from the tripartite network which are further used for ADR prediction. Through this approach, drug-ADR associations could possibly be discovered from a systemic perspective. The accuracy of our method is 0.95 based on internal resource validation and 0.88 based on external resource validation. Moreover, our results show the prediction accuracy using the tripartite network is better than the one with bipartite network, suggesting the model performance can be improved with further enrichment on information. According to the result of 10-fold cross validation, the deep learning model outperforms two traditional methods (topology-based measures and chemical structure-based measures). Additionally, predictive models are also constructed using other deep learning methods, and comparable results are achieved. In summary, the biomedical tripartite network-based deep learning model proposed here proves to offer a promising solution for prediction of ADRs.

Entities:  

Year:  2019        PMID: 31777246     DOI: 10.1021/acs.chemrestox.9b00238

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  4 in total

Review 1.  Artificial intelligence to deep learning: machine intelligence approach for drug discovery.

Authors:  Rohan Gupta; Devesh Srivastava; Mehar Sahu; Swati Tiwari; Rashmi K Ambasta; Pravir Kumar
Journal:  Mol Divers       Date:  2021-04-12       Impact factor: 3.364

2.  Drug-target-ADR Network and Possible Implications of Structural Variants in Adverse Events.

Authors:  Bryan Dafniet; Natacha Cerisier; Karine Audouze; Olivier Taboureau
Journal:  Mol Inform       Date:  2020-08-28       Impact factor: 3.353

Review 3.  New avenues for systematically inferring cell-cell communication: through single-cell transcriptomics data.

Authors:  Xin Shao; Xiaoyan Lu; Jie Liao; Huajun Chen; Xiaohui Fan
Journal:  Protein Cell       Date:  2020-05-21       Impact factor: 14.870

4.  PregTox: A Resource of Knowledge about Drug Fetal Toxicity.

Authors:  Qingqing Chen; Yu Gan; Kejian Wang; Qing Li
Journal:  Biomed Res Int       Date:  2022-04-16       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.